Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome. - Wikidata - awgldk - TriplyDB

Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.

Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.

http://www.wikidata.org/entity/Q38202612

about

p53 Proteoforms and Intrinsic Disorder: An Illustration of the Protein Structure-Function Continuum Concept Endometrial cancer gene panels: clinical diagnostic vs research germline DNA testing.Intensified surveillance for early detection of breast cancer in high-risk patients Breast liposarcoma with solitary metastasis to the pleura: A case report.Whole genome sequence analysis suggests intratumoral heterogeneity in dissemination of breast cancer to lymph nodes Concise review: hematopoietic stem cell aging and the prospects for rejuvenation Lobular breast cancer: incidence and genetic and non-genetic risk factors.Polymorphisms in TP53 are associated with risk and survival of osteosarcoma in a Chinese population Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous niche A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.Recent developments in brain tumor predisposing syndromes.DNA methylation patterns of candidate genes regulated by thymine DNA glycosylase in patients with TP53 germline mutations.Using a family history questionnaire to identify adult patients with increased genetic risk for sarcoma.Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond Li-Fraumeni Syndrome THE GORDON WILSON LECTURE EVOLUTION OF CLINICAL CANCER GENETICS.Haploinsufficiency networks identify targetable patterns of allelic deficiency in low mutation ovarian cancer.TP53 mutations in human cancer: database reassessment and prospects for the next decade.Recommendations for analyzing and reporting TP53 gene variants in the high-throughput sequencing era.The TP53 gene network in a postgenomic era.Lung Adenocarcinoma as Part of the Li-Fraumeni Syndrome Spectrum: Preliminary Data of the LIFSCREEN Randomized Clinical Trial.Genetic predisposition to hematologic malignancies: management and surveillance.Should Genetic Testing be Offered for Children? The Perspectives of Adolescents and Emerging Adults in Families with Li-Fraumeni Syndrome.Next generation sequencing is informing phenotype: a TP53 example.Advances in Hereditary Colorectal and Pancreatic Cancers.Tumor-Suppressor Functions of the TP53 Pathway.Clinical Outcomes of TP53 Mutations in Cancers.Frequency of Thyroid Carcinoma in Brazilian TP53 p.R337H Carriers With Li Fraumeni Syndrome.Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition.Easing the Burden: Describing the Role of Social, Emotional and Spiritual Support in Research Families with Li-Fraumeni Syndrome.Puzzles in modern biology. III.Two kinds of causality in age-related disease.Care delivery considerations for widespread and equitable implementation of inherited cancer predisposition testing.TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family.Allele-specific wild-type TP53 expression in the unaffected carrier parent of children with Li-Fraumeni syndrome.Importance of updating family cancer history in childhood cancer survivors.Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children.Gestational choriocarcinoma associated with a germline TP53 mutation.Whole-exome analysis of a Li-Fraumeni family trio with a novel TP53 PRD mutation and anticipation profile.Pleomorphic myxoid liposarcoma in an adolescent with Li-Fraumeni syndrome.

P2860

Q28079390-5024221F-E091-43C4-A08F-174755E5ACDC Q30234614-83A524F5-E96F-436B-AFEC-461C96F5C900 Q30392157-368DA9DB-DA46-4E65-90CA-32DA51E44525 Q33885787-C9F196BC-9F30-4CB8-A50D-D7DFA040C001 Q34784863-0E8FCCA5-DC24-4EC9-B33B-58A3907A8C06 Q35001363-E8816732-C220-4219-8E02-EAABDA067034 Q35170028-2F5127C2-5AB4-4C2D-8C4C-9ECCCFCB894F Q35632374-0C4E7FD2-F7C0-4FE8-BA57-3C5A4F5D34D3 Q35717532-F9D8744F-E8FF-408F-B885-120C8449BA81 Q35786931-821FB120-4254-4DFF-945E-FAB959C13771 Q35860402-DA52A57A-CD8A-40BF-9C73-7D0583223784 Q35881338-1FADF364-11AA-44EA-BE8C-A940B9C26191 Q36169808-2052B608-0465-449F-B070-473284A00CB2 Q36619933-A54290C9-1584-4A1F-8179-0FED0542A212 Q37032644-BD0AF608-469E-494E-9E15-828F85B181AD Q37563869-B1220E19-3D4B-4F83-916F-5F81ED1B0731 Q37651932-720C541D-0A8C-4BDF-BBDA-5585095AC0BD Q38199075-B668333E-A398-436F-9B56-11CDF41693C3 Q38204360-3F7D485A-BBA2-42AC-A107-3ADCE99ABFD9 Q38206172-AE60FE32-EFB3-4664-A07F-7BEE97481B67 Q38643814-608E5BCD-514B-4583-A6F0-643B251C5633 Q38733102-71C33FBF-E403-408E-BA58-69BBB07AC788 Q38743800-887F3BFF-433B-4F94-A9DB-A6EA1C07DAFB Q38783154-5132878F-9865-4135-99BD-6E40566BB7F8 Q38798530-B1251B1A-16C2-411F-9BBE-37F7DA5C54E1 Q38824332-83D4BE7F-23DD-4F27-B7C5-8F10A7F1EBE3 Q38906201-60345005-D02C-4E92-B177-2BA3C8B7FAC9 Q39004018-2DE914C8-6D02-4956-9E4A-51FA7D878D81 Q39041480-6556879F-7D51-4AFC-87F3-68A124A7BDC9 Q39284496-DE6FB6D0-B31C-473B-834E-6EF95BBF5836 Q40339155-EAF8FD8C-2D6E-4CB9-92C7-349BC75BE43A Q40445128-70218594-B534-480D-A569-3AF92788026C Q41733541-22CBDCC3-D9FA-43FB-9396-29DBA980B4A4 Q42775929-F2754253-DB67-4B92-8752-57A892D27C92 Q44931397-FF1AE5EE-3475-400D-810D-B7CCEE3315C4 Q47369258-98255289-B96C-4392-B830-C027251358AF Q47564553-A6102D1B-DB43-4D79-A13A-12BF462F3B53 Q47772572-35CDAF49-73AE-4F46-B7EE-95B6126F8632 Q47801891-4311BF11-6A57-4E30-BE4B-B2C9E2F216AE Q47870586-526D64E4-E073-47AF-9B30-3B1F9DD38A37

P2860

Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.

http://www.wikidata.org/entity/Q38202612

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.

@en

type

label

Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.

@en

prefLabel

Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.

@en

P1433

Q38202612-10CD50B8-7729-462C-AD5C-31D0EEACFD5A

P1476

Q38202612-4291B24A-9B2D-462F-AE58-F7F28D632D55

P2093

Q38202612-2C44C7E1-2BE5-4216-8EA2-3CC0BDC8E679

Q38202612-7D91DF04-9000-44DA-8081-1526B1C44903

P2860

Q38202612-02B09D64-687A-4698-A2AD-BC9CCCB19A55

Q38202612-117367DB-EB3F-4E33-AAC8-E073909FC2B7

Q38202612-16627DD0-8526-443D-8A5B-347030080573

Q38202612-17C7244D-FE3E-449E-A4A8-80A0920B0CA4

Q38202612-180C6B49-531E-466D-8C2C-AF19F6926BFD

Q38202612-1868ACC9-0AFD-46D1-A029-8BE7FF21FC40

Q38202612-1B27EE86-0408-4196-9F4E-E1F3E2DD2869

Q38202612-1B2D2359-B99A-43AA-8CCD-C5B567B03680

Q38202612-20FA79A1-888E-49EB-A363-CE59FC78DC5F

Q38202612-25B9D4EF-B785-4EEE-AA79-2F7F42922200

P304

Q38202612-F8E023F1-B6D0-475C-BEB2-AE74B27279DD

P31

Q38202612-2B58C641-5644-4374-A4BF-6FD66D9AE9B5

P356

Q38202612-39674645-B122-47D1-A927-0C8C720E18DC

P433

Q38202612-B62B84E3-FB4B-4F9E-8930-9A7787548E32

P478

Q38202612-A9276AFF-FA7F-4C7E-984C-7790778E6F92

P50

Q38202612-F205CF2B-F4B4-4FE2-8698-D745EE534429

P577

Q38202612-49B011C3-BABB-478F-85A5-C08E399DED90

P5875

Q38202612-88780AB3-160A-408D-B405-AA789466EBB4

P698

Q38202612-55D16DFF-C4C1-4302-BCBA-DC2833702CBE

P356

P1433

P1476

Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.

@en

P2093

Judy E Garber

http://www.w3.org/2001/XMLSchema#string

Junne Kamihara

http://www.w3.org/2001/XMLSchema#string

P2860

Surfing the p53 network

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors.

Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer

Association of the germline TP53 R337H mutation with breast cancer in southern Brazil.

TP53 mutations in human cancers: origins, consequences, and clinical use

Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk

An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.

Germline TP53 mutations and Li-Fraumeni syndrome.

P304

654-662

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HUMU.22559

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261376833

http://www.w3.org/2001/XMLSchema#string

P698

24706533

http://www.w3.org/2001/XMLSchema#string